VIP and psoriasis: We provide the first evidence of the association between low serum VIP levels and increased disease severity in patients with early SpA, namely, impaired functional status, bone edema in MRI, and a more intense inflammatory burden (anemia, psoriasis, IBD, and enthesitis).